Charmacy Pharmaceutical Co., Ltd. Class H (HK:2289)
:2289
Want to see HK:2289 full AI Analyst Report?
Total Valuation
Charmacy Pharmaceutical Co., Ltd. Class H has a market cap or net worth of HK$590.76M. The enterprise value is HK$1.85B.
Market CapHK$590.76M
Enterprise ValueHK$1.85B
Share Statistics
Charmacy Pharmaceutical Co., Ltd. Class H has 108,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding108,000,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Charmacy Pharmaceutical Co., Ltd. Class H’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 1.81%.
Return on Equity (ROE)0.08
Return on Assets (ROA)0.01
Return on Invested Capital (ROIC)1.81%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee5.18M
Profits Per Employee59.25K
Employee Count847
Asset Turnover1.11
Inventory Turnover5.08
Valuation Ratios
The current PE Ratio of Charmacy Pharmaceutical Co., Ltd. Class H is 11.5. Charmacy Pharmaceutical Co., Ltd. Class H’s PEG ratio is -1.25.
PE Ratio11.5
PS Ratio0.16
PB Ratio1.15
Price to Fair Value1.15
Price to FCF2.68
Price to Operating Cash Flow1.82
PEG Ratio-1.25
Income Statement
In the last 12 months, Charmacy Pharmaceutical Co., Ltd. Class H had revenue of 4.38B and earned 46.27M in profits. Earnings per share was 0.43.
Revenue4.38B
Gross Profit336.01M
Operating Income68.10M
Pretax Income64.31M
Net Income46.27M
EBITDA152.14M
Earnings Per Share (EPS)0.43
Cash Flow
In the last 12 months, operating cash flow was 265.54M and capital expenditures -7.73M, giving a free cash flow of 257.81M billion.
Operating Cash Flow265.54M
Free Cash Flow257.81M
Free Cash Flow per Share2.39
Dividends & Yields
Charmacy Pharmaceutical Co., Ltd. Class H pays an annual dividend of HK$0.344, resulting in a dividend yield of 8.03%
Dividend Per ShareHK$0.344
Dividend Yield8.03%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.14
52-Week Price Change-13.45%
50-Day Moving Average5.48
200-Day Moving Average5.69
Relative Strength Index (RSI)97.19
Average Volume (3m)283.00
Important Dates
Charmacy Pharmaceutical Co., Ltd. Class H upcoming earnings date is Sep 2, 2026, TBA (Confirmed).
Last Earnings DateMar 27, 2026
Next Earnings DateSep 2, 2026
Ex-Dividend Date―
Financial Position
Charmacy Pharmaceutical Co., Ltd. Class H as a current ratio of 1.09, with Debt / Equity ratio of 338.89%
Current Ratio1.09
Quick Ratio0.84
Debt to Market Cap2.92
Net Debt to EBITDA8.78
Interest Coverage Ratio1.11
Taxes
In the past 12 months, Charmacy Pharmaceutical Co., Ltd. Class H has paid 18.04M in taxes.
Income Tax18.04M
Effective Tax Rate0.28
Enterprise Valuation
Charmacy Pharmaceutical Co., Ltd. Class H EV to EBITDA ratio is 13.43, with an EV/FCF ratio of 7.76.
EV to Sales0.47
EV to EBITDA13.43
EV to Free Cash Flow7.76
EV to Operating Cash Flow7.54
Balance Sheet
Charmacy Pharmaceutical Co., Ltd. Class H has HK$753.92M in cash and marketable securities with HK$2.09B in debt, giving a net cash position of -HK$1.34B billion.
Cash & Marketable SecuritiesHK$753.92M
Total DebtHK$2.09B
Net Cash-HK$1.34B
Net Cash Per Share-HK$12.37
Tangible Book Value Per ShareHK$5.02
Margins
Gross margin is 7.76%, with operating margin of 1.55%, and net profit margin of 1.06%.
Gross Margin7.76%
Operating Margin1.55%
Pretax Margin1.47%
Net Profit Margin1.06%
EBITDA Margin3.47%
EBIT Margin3.00%
Analyst Forecast
The average price target for Charmacy Pharmaceutical Co., Ltd. Class H is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-1.11%
EPS Growth Forecast-13.09%